Exposed: 10 CENT Crypto to Explode April 20th?

The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…

Shawn Assad Biography and Net Worth

CAO of GeneDx

Shawn Assad holds the position of Chief Accounting Officer for Sema4 Holdings Corp.

In his past career Mr. Assad occupied the position of Senior Vice President-Assistant Global Controller at Endeavor Group Holdings, Inc., Chief Accounting Officer & Global Controller at VICE Media LLC and Partner at Corporate Finance Group, Inc.

Shawn Assad received an undergraduate degree from Northeastern University and an undergraduate degree from PSB Paris School of Business.

What is Shawn Assad's net worth?: The estimated net worth of Shawn Assad is at least $10,857.24 as of May 11th, 2022. Mr. Assad owns 972 shares of GeneDx stock worth more than $10,857 as of April 26th. This net worth evaluation does not reflect any other investments that Mr. Assad may own. Learn More about Shawn Assad's net worth.
How do I contact Shawn Assad?: The corporate mailing address for Mr. Assad and other GeneDx executives is 333 Ludlow Street North Tower 8th Floor, Stamford CT, 06902. GeneDx can also be reached via phone at 800-298-6470 and via email at [email protected]. Learn More on Shawn Assad's contact information.
Has Shawn Assad been buying or selling shares of GeneDx?: Shawn Assad has not been actively trading shares of GeneDx during the last quarter. Most recently, Shawn Assad sold 94 shares of the business's stock in a transaction on Wednesday, May 11th. The shares were sold at an average price of $57.75, for a transaction totalling $5,428.50. Following the completion of the sale, the chief accounting officer now directly owns 972 shares of the company's stock, valued at $56,133. Learn More on Shawn Assad's trading history.
Who are GeneDx's active insiders?: GeneDx's insider roster includes Shawn Assad (CAO), Daniel Clark (General Counsel), James Coffin (COO), Anthony Prentice (Insider), Isaac Ro (CFO), and Eric Schadt (CEO). Learn More on GeneDx's active insiders.
Are insiders buying or selling shares of GeneDx?: In the last year, GeneDx insiders bought shares 5 times. They purchased a total of 116,742 shares worth more than $491,562.34. In the last year, insiders at the sold shares 32 times. They sold a total of 78,286 shares worth more than $445,847.63. The most recent insider tranaction occured on March, 18th when CEO Katherine Stueland sold 8,559 shares worth more than $90,639.81. Insiders at GeneDx own 28.1% of the company. Learn More about insider trades at GeneDx.
Information on this page was last updated on 3/18/2024.

Shawn Assad Insider Trading History at GeneDx

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/11/2022	Sell	94	$57.75	$5,428.50	972
2/11/2022	Sell	110	$120.12	$13,213.20
11/10/2021	Sell	94	$259.71	$24,412.74

Shawn Assad Buying and Selling Activity at GeneDx

GeneDx Company Overview

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

Today's Range

Now: $11.17

$11.00

$11.61

50 Day Range

MA: $9.15

$5.05

$12.01

2 Week Range

Now: $11.17

$1.16

$12.57

Volume

104,349 shs

Average Volume

241,508 shs

Market Capitalization

$290.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.75

Exposed: 10 CENT Crypto to Explode April 20th?

From True Market Insiders | Ad